Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 5
2013 6
2014 5
2015 6
2016 8
2017 9
2018 13
2019 16
2020 30
2021 28
2022 34
2023 19
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study.
Balar AV, Kamat AM, Kulkarni GS, Uchio EM, Boormans JL, Roumiguié M, Krieger LEM, Singer EA, Bajorin DF, Grivas P, Seo HK, Nishiyama H, Konety BR, Li H, Nam K, Kapadia E, Frenkl T, de Wit R. Balar AV, et al. Among authors: roumiguie m. Lancet Oncol. 2021 Jul;22(7):919-930. doi: 10.1016/S1470-2045(21)00147-9. Epub 2021 May 26. Lancet Oncol. 2021. PMID: 34051177 Clinical Trial.
Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review.
Soorojebally Y, Neuzillet Y, Roumiguié M, Lamy PJ, Allory Y, Descotes F, Ferlicot S, Kassab-Chahmi D, Oudard S, Rébillard X, Roy C, Lebret T, Rouprêt M, Audenet F. Soorojebally Y, et al. Among authors: roumiguie m. World J Urol. 2023 Feb;41(2):345-359. doi: 10.1007/s00345-022-04253-3. Epub 2023 Jan 2. World J Urol. 2023. PMID: 36592175 Review.
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies.
Gandaglia G, Ploussard G, Valerio M, Mattei A, Fiori C, Fossati N, Stabile A, Beauval JB, Malavaud B, Roumiguié M, Robesti D, Dell'Oglio P, Moschini M, Zamboni S, Rakauskas A, De Cobelli F, Porpiglia F, Montorsi F, Briganti A. Gandaglia G, et al. Among authors: roumiguie m. Eur Urol. 2019 Mar;75(3):506-514. doi: 10.1016/j.eururo.2018.10.012. Epub 2018 Oct 17. Eur Urol. 2019. PMID: 30342844 Free article.
Radium 223 dichloride for prostate cancer treatment.
Deshayes E, Roumiguie M, Thibault C, Beuzeboc P, Cachin F, Hennequin C, Huglo D, Rozet F, Kassab-Chahmi D, Rebillard X, Houédé N. Deshayes E, et al. Among authors: roumiguie m. Drug Des Devel Ther. 2017 Sep 6;11:2643-2651. doi: 10.2147/DDDT.S122417. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28919714 Free PMC article. Review.
International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin-exposed High-risk Non-muscle-invasive Bladder Cancer.
Roumiguié M, Kamat AM, Bivalacqua TJ, Lerner SP, Kassouf W, Böhle A, Brausi M, Buckley R, Persad R, Colombel M, Lamm D, Palou-Redorta J, Soloway M, Brothers K, Steinberg G, Lotan Y, Sylvester R, Alfred Witjes J, Black PC. Roumiguié M, et al. Eur Urol. 2022 Jul;82(1):34-46. doi: 10.1016/j.eururo.2021.12.005. Epub 2021 Dec 23. Eur Urol. 2022. PMID: 34955291 Review.
Age represents the main driver of surgical decision making in patients candidate to radical cystectomy.
Dell'Oglio P, Tappero S, Panunzio A, Antonelli A, Salvador D, Xylinas E, Alvarez-Maestro M, Hurle R, Salas RS, Colomer A, Simone G, Hendricksen K, Peroni A, Lonati C, Olivero A, Rouprêt M, Roumiguié M, Soria F, Umari P, D'Andrea D, Terrone C, Galfano A, Moschini M, Trapani ED; European Association of Urology-Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group. Dell'Oglio P, et al. Among authors: roumiguie m. J Surg Oncol. 2023 Jul;128(1):142-154. doi: 10.1002/jso.27255. Epub 2023 May 1. J Surg Oncol. 2023. PMID: 37126407
Prognostic value of programmed death ligand-1 and programmed death-1 expression in patients with upper tract urothelial carcinoma.
Campedel L, Compérat E, Cancel-Tassin G, Varinot J, Pfister C, Delcourt C, Gobet F, Roumiguié M, Patard PM, Daniel G, Bigot P, Carrouget J, Eymerit C, Larré S, Léon P, Durlach A, Ruffion A, de Mazancourt ES, Decaussin-Petrucci M, Bessède T, Lebacle C, Ferlicot S, Robert G, Vuong NS, Philip M, Crouzet S, Matillon X, Mège-Lechevallier F, Lang H, Mouracade P, Lindner V, Gougis P, Cussenot O, Rouprêt M, Seisen T. Campedel L, et al. Among authors: roumiguie m. BJU Int. 2023 Nov;132(5):581-590. doi: 10.1111/bju.16129. Epub 2023 Aug 10. BJU Int. 2023. PMID: 37488983
Adherent perinephric fat affects perioperative outcomes after partial nephrectomy: a systematic review and meta-analysis.
Khene ZE, Dosin G, Peyronnet B, Gasmi A, Doumerc N, Ouzaid I, Pradere B, Brassier M, Roumiguié M, Mathieu R, Rioux-Leclercq N, Raman JD, Shariat S, Bensalah K. Khene ZE, et al. Among authors: roumiguie m. Int J Clin Oncol. 2021 Apr;26(4):636-646. doi: 10.1007/s10147-021-01871-6. Epub 2021 Jan 27. Int J Clin Oncol. 2021. PMID: 33502646 Review.
137 results